BSH 2019 | CARPALL and AMELIA: ongoing data for CAR-T in ALL

Sara Ghorashian

We spoke to Sara Ghorashian, PhD, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK, about the CARPALL (NCT02443831) and AMELIA (NCT03289455) trials. CARPALL is looking at CD19 CAR-T for young patients with relapsed acute lymphoblastic leukemia (ALL), while AMELIA is investigating CD19/22 CAR T-cells (AUTO3) for the treatment of relapsed/refractory B-cell ALL. This interview took place at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK.

Share this video